Law360, Philadelphia (December 13, 2016, 5:38 PM EST) -- A midtrial ruling by a Philadelphia judge rejecting expert causation testimony brought a premature end Tuesday to the latest case over allegations that the Johnson & Johnson antipsychotic drug Risperdal caused an adolescent boy to grow female breasts.
Judge Sean Kennedy in the Philadelphia County Court of Common Pleas ruled from the bench on Tuesday morning that expert testimony offered by Mark Solomon could not support claims that Risperdal caused Tommy Moroni to develop breasts after he began taking the powerful antipsychotic as a 7-year-old boy living in Wichita Falls, Texas, in 2004.
"At the conclusion of my research and my...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!